Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production

70Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fatty acid synthase (FASN) is a key enzyme in the synthesis of palmitate, the precursor of major nutritional, energetic, and signaling lipids. FASN expression is upregulated in many human cancers and appears to be important for cancer cell survival. Overexpression of FASN has also been found to associate with poor prognosis and higher risk of recurrence of human cancers. Indeed, elevated FASN expression has been shown to contribute to drug resistance. However, the mechanism of FASN-mediated drug resistance is currently unknown. In this study, we show that FASN overexpression causes resistance to multiple anticancer drugs via inhibiting drug-induced ceramide production, caspase 8 activation, and apoptosis. We also show that FASN overexpression suppresses tumor necrosis factor- production and nuclear factor-B activation as well as drug-induced activation of neutral sphingomyelinase. Thus, TNF-may play an important role in mediating FASN function in drug resistance.Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc..

Cite

CITATION STYLE

APA

Liu, H., Wu, X., Dong, Z., Luo, Z., Zhao, Z., Xu, Y., & Zhang, J. T. (2013). Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production. Journal of Lipid Research, 54(3), 776–785. https://doi.org/10.1194/jlr.M033811

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free